| COVID-19 Latika | hK50aD3C6X |
| NASH | Occ6z69LOO |
| A9 regulated networks across human cancers (Publication: Nature Communications, 2019) | KGRHw7WPn4 |
| B4 Diagnostic/Prognostic Biomarker in Head and Neck Cancer (Publication: Cancers, 2020) | TBrC6BecRv |
| Hepatocarcinogenesis Biomarker (Publication: Cancers, 2019) | ITQjlPu1Pf |
| Latent Tuberculosis Infection (LTBI) Diagnostic Panel for Prevention SDR | UUjc2p6adt |
| Fatty liver (Human HepG2, FC>1.5) | uwJFELSNvr |
| Fatty Liver (NALFD) Drug Development (JMY104) | RkMZRz3cd0 |
| NASH+HCC | |
| TNBC highly metastatic animal model+Knock out (microarray) | WF31DokQA1 |
| TNBC highly metastatic animal model (microarray) | aLujGQ4anK |
| TNBC highly metastatic animal model (NGS) | zLcvIfCjE0 |
| TNBC JMY104 case | dhyaijc6Yw |
| SMA (public_human) | 5xmlT3uS8o |
